Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for iRay Group's FCF Yield % or its related term are showing as below:
SHSE:688301'
s FCF Yield % Range Over the Past 10 Years
Min: -12.83 Med: -1.32 Max: 2.18
Current: -3.96
During the past 11 years, the highest FCF Yield % of iRay Group was 2.18%. The lowest was -12.83%. And the median was -1.32%.
SHSE:688301's FCF Yield % is ranked worse than 63.16% of 847
companies
in the Medical Devices & Instruments industry
Industry Median: -0.41
vs SHSE:688301: -3.96
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
iRay Group FCF Yield % Related Terms
iRay Group FCF Yield % Historical Data
* Premium members only.
The historical data trend for iRay Group's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688301 vs ISRG, BDX, RMD: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, iRay Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRay Group FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRay Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where iRay Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRay Group (SHSE:688301) has a FCF Yield % of -3.96 as of Sep. 12, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on iRay Group and its competitors. According to the industry distribution chart, iRay Group ranks #535 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 63.2%.
Is iRay Group's FCF Yield % too high?
iRay Group's current FCF Yield % is -3.96. Based on the distribution chart, iRay Group ranks #535 out of 847 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, iRay Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRay Group's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, iRay Group ranks #535 out of 847 companies for FCF Yield %. This places iRay Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on iRay Group and its competitors. iRay Group's current FCF Yield % is -3.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRay Group stock overvalued right now?
Based on GuruFocus' analysis, iRay Group (SHSE:688301) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥110.12, compared to a current price of ¥88.54 — trading 19.6% below its estimated fair value. The current FCF Yield % is -3.96. iRay Group's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For iRay Group (SHSE:688301), the current FCF Yield % is -3.96 as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRay Group (SHSE:688301) Overvalued in 2026?
Based on GuruFocus' analysis, iRay Group stock appears to be undervalued.
The current stock price of ¥88.54 is trading 19.6% below its estimated GF Value™ of ¥110.12.
GuruFocus considers iRay Group to be Modestly Undervalued.
Key valuation signals for SHSE:688301:
FCF Yield %: -3.96
GF Value™: ¥110.12 vs. price of ¥88.54 (19.6% below fair value)
No single metric tells the full story. See the SHSE:688301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688301 has been successfully added to your 
